Oncology Companion Diagnostic Market is likely to exhibit CAGR of 13.3%, and estimated to hit worth of USD 10.57 Billion by year 2032 end | PMR

The ability of companion diagnostics to facilitate early cancer detection and screening initiatives is a major trend supporting industry development. By technology analysis, the immunohistochemistry segment witnessed the largest revenue share in 2022. By region analysis, the Asia Pacific region is anticipated to experience significant growth.

𝐊𝐞𝐲 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The global oncology companion diagnostic market was valued at USD 3.45 billion in 2023 and is expected to grow to USD 10.57 billion by 2032.
• The industry is projected to grow at a compound annual growth rate (CAGR) of 13.3% over the estimated period of 2024 to 2032.
• The market is primarily segmented based on offering, technology, disease type, end user, and region.
• The major regions covered in the market report include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.polarismarketresearch.com/industry-analysis/oncology-companion-diagnostic-market/request-for-sample

𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
Oncology companion diagnostic is a medical device that offers information essential for the safe and effective use of targeted therapies. A companion diagnostic test is used to determine the treatment option a patient is likely to benefit from. To help determine the best treatment plan, data about the genomic alterations with the patient's tumor is considered. Companion diagnostics play a vital role in personalized medicine, enabling oncologists to choose the most appropriate treatment based on their unique genetic profile. Oncology companion diagnostic finds application in the treatment of various diseases, including melanoma, breast cancer, colorectal cancer, leukemia, and prostate cancer, amongst others.

𝐌𝐚𝐣𝐨𝐫 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬

• The oncology companion diagnostic market is characterized by fragmentation. The industry has the presence of several key players who are constantly upgrading their technology to strengthen their market position. Among the major industry participants include:
• Abbott Laboratories
• Agilent Technologies
• Bio-Rad Laboratories
• Biocartis
• Exact Sciences
• Genedrive
• Genomic Health
• Guardant Health
• Illumina
• Invivoscribe
• Myriad Genetics
• QIAGEN
• Roche Diagnostics
• Sysmex Corporation
• Thermo Fisher Scientific

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/buy/3099/2

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬
• The global rise in cancer incidence is a fundamental driver of the market. The rising prevalence of various cancer types highlights the need for advanced diagnostic tools that facilitate accurate patient stratification.

• The rising availability of targeted cancer therapies is another factor that boosts market development. Companion diagnostics enable the delivery of highly effective treatments while minimizing the side effects linked to broad-spectrum approaches.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐁𝐫𝐨𝐰𝐬𝐞 𝐀𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐞𝐭𝐚𝐢𝐥𝐬 : https://www.polarismarketresearch.com/industry-analysis/oncology-companion-diagnostic-market

𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐨𝐧 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• Product segment held a significant share in 2022, owing to growing cancer prevalence, global aging population, and advancements in precision medicine

• Immunohistochemistry emerged as the largest segment on account of its wide use in biomarker detection, subtype classification, and treatment guidance

• The breast cancer segment is expected to experience significant growth during the forecast period, which is mainly driven by its growing adoption of targeted therapies and regulatory support

• Hospitals segment held the maximum market revenue share in 2022, mainly for early detection and diagnosis, treatment monitoring, and patient-centric care

• North America region dominated the market with majority share in 2022, owing to the rise of personalized medicine, regulatory framework, and partnerships and collaborations

𝐓𝐨𝐩 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐨𝐟 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

𝙏𝙚𝙡𝙚𝙧𝙚𝙝𝙖𝙗𝙞𝙡𝙞𝙩𝙖𝙩𝙞𝙤𝙣 𝙈𝙖𝙧𝙠𝙚𝙩 : https://www.polarismarketresearch.com/industry-analysis/telerehabilitation-market
𝙋𝙧𝙞𝙫𝙖𝙩𝙚 𝙉𝙪𝙧𝙨𝙞𝙣𝙜 𝙎𝙚𝙧𝙫𝙞𝙘𝙚𝙨 𝙈𝙖𝙧𝙠𝙚𝙩 : https://www.polarismarketresearch.com/industry-analysis/private-nursing-services-market
𝘼𝙡𝙥𝙤𝙧𝙩 𝙎𝙮𝙣𝙙𝙧𝙤𝙢𝙚 𝙏𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 𝙈𝙖𝙧𝙠𝙚𝙩 : https://www.polarismarketresearch.com/industry-analysis/alport-syndrome-treatment-market
𝘼𝙣𝙞𝙢𝙖𝙡 𝙐𝙡𝙩𝙧𝙖𝙨𝙤𝙪𝙣𝙙 𝙈𝙖𝙧𝙠𝙚𝙩 : https://www.polarismarketresearch.com/industry-analysis/animal-ultrasound-market
𝙊𝙩𝙤𝙨𝙘𝙤𝙥𝙚 𝙈𝙖𝙧𝙠𝙚𝙩 : https://www.polarismarketresearch.com/industry-analysis/otoscope-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.